Profil

FOIDART Pierre

Département de médecine interne > Service d'oncologie médicale

See author's contact details
Main Referenced Co-authors
Noël, Agnès  (9)
Sounni, Nor Eddine  (9)
Yip, Cassandre  (7)
Jerusalem, Guy  (6)
Collignon, Joëlle  (4)
Main Referenced Keywords
MT4-MMP (3); Animals (2); EGFR (2); Humans (2); Acanthocytes (1);
Main Referenced Unit & Research Centers
Laboratoire de Biologie des Tumeurs et du Developpement (1)
Main Referenced Disciplines
Oncology (11)
Anesthesia & intensive care (1)
Gastroenterology & hepatology (1)
Reproductive medicine (gynecology, andrology, obstetrics) (1)
Biochemistry, biophysics & molecular biology (1)

Publications (total 16)

The most downloaded
10522 downloads
Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534. https://hdl.handle.net/2268/242373

The most cited

79 citations (Scopus®)

Coussy, F., El-Botty, R., Château-Joubert, S., Dahmani, A., Montaudon, E., Leboucher, S., Morisset, L., Painsec, P., Sourd, L., Huguet, L., Nemati, F., Servely, J.-L., Larcher, T., Vacher, S., Briaux, A., Reyes, C., La Rosa, P., Lucotte, G., Popova, T., ... Marangoni, E. (2020). BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science Translational Medicine, 12 (532). doi:10.1126/scitranslmed.aax2625 https://hdl.handle.net/2268/249408

Alečković, M., Li, Z., Zhou, N., Qiu, X., Lulseged, B., Foidart, P., Huang, X.-Y., Garza, K., Shu, S., Kesten, N., Li, R., Lim, K., Garrido-Castro, A. C., Guerriero, J. L., Qi, J., Long, H. W., & Polyak, K. (01 November 2023). Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer. Molecular Cancer Therapeutics, 22 (11), 1304 - 1318. doi:10.1158/1535-7163.MCT-23-0303
Peer Reviewed verified by ORBi

Foidart, P. (12 May 2023). The Whole genome doubling leads to an immune escape in TNBC [Paper presentation]. Molecular and cellular oncology -Dana-Farber conference, Cambridge, United States.

Alečković, M., Cristea, S., Gil Del Alcazar, C. R., Yan, P., Ding, L., Krop, E. D., Harper, N. W., Rojas Jimenez, E., Lu, D., Gulvady, A. C., Foidart, P., Seehawer, M., Diciaccio, B., Murphy, K. C., Pyrdol, J., Anand, J., Garza, K., Wucherpfennig, K. W., Tamimi, R. M., ... Polyak, K. (07 December 2022). Breast cancer prevention by short-term inhibition of TGFβ signaling. Nature Communications, 13 (1), 7558. doi:10.1038/s41467-022-35043-5
Peer Reviewed verified by ORBi

Hamdi, J., FOIDART, P., & Ali, D. (2021). Mediastinal malposition of a catheter enhanced by an unusual stenosis of the left brachiocephalic vein due to a former long-term haemodialysis catheter. Journal of Medical Case Reports and Case Serie.
Peer reviewed

Coussy, F., El-Botty, R., Château-Joubert, S., Dahmani, A., Montaudon, E., Leboucher, S., Morisset, L., Painsec, P., Sourd, L., Huguet, L., Nemati, F., Servely, J.-L., Larcher, T., Vacher, S., Briaux, A., Reyes, C., La Rosa, P., Lucotte, G., Popova, T., ... Marangoni, E. (2020). BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers. Science Translational Medicine, 12 (532). doi:10.1126/scitranslmed.aax2625
Peer Reviewed verified by ORBi

Foidart, P. (28 January 2019). Novel combination of target therapies in TNBC based on definition of biomarkers [Paper presentation]. Séminaire des chercheurs Télévie 2019.

Yip, C., FOIDART, P., Noël, A., & Sounni, N. E. (16 January 2019). MT4-MMP: The GPI-Anchored Membrane-Type Matrix Metalloprotease with Multiple Functions in Diseases. International Journal of Molecular Sciences, 20 (2). doi:10.3390/ijms20020354
Peer Reviewed verified by ORBi

Delmotte, V., Foidart, P., DE VOEGHT, A., LEJEUNE, M., & Delwaide, J. (2019). Diagnostic différentiel de l’anémie dans la cirrhose éthylique. Revue Médicale de Liège, 74 (10), 527-534.
Peer reviewed

FOIDART, P., Yip, C., Radermacher, J., Blacher, S., Lienard, M., MONTERORUIZ, L., Maquoi, E., Montaudon, E., Chateau-Joubert, S., COLLIGNON, J., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E.* , & JERUSALEM, G.*. (2019). Expression of MT4-MMP, EGFR, and RB in Triple-Negative Breast Cancer Strongly Sensitizes Tumors to Erlotinib and Palbociclib Combination Therapy. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-18-1880
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

FOIDART, P. (02 July 2018). “MT4-MMP, EGFR and Rb expressions are predictive biomarkers of response to Erlotinib-Palbociclib combination in TNBC” [Poster presentation]. 25ème Congrès de l'EARC (Association européenne de recherche sur le cancer), Amsterdam, Netherlands.

FOIDART, P., Yip, C., Radermacher, J., MONTERORUIZ, L., Coibion, M., Jossa, V., Marangoni, E., Noël, A., Sounni, N. E., & JERUSALEM, G. (24 February 2018). MT4-MMP, EGFR and RB expressions are predictive biomarkers of response to Erlotinib-Palbociclib combination in TNBC [Paper presentation]. Belgian Society of Medical Oncology: annual meeting, Ostende, Belgium.

FOIDART, P., Yip, C., Radermacher, J., MONTERORUIZ, L., Marangoni, E., Noël, A., Sounni, N. E., JERUSALEM, G., Coibion, M., Jossa, V., & BLACHER, S. (27 January 2018). Expression of MT4-MMP, EGFR and Rb in triple negative breast cancers strongly sensitizes tumors to Erlotinib and Palbociclib combination therapy [Paper presentation]. Belgian Association for Cancer Research : Annual Meeting, Liège, Belgium.

Marangoni, E., Laurent, C., Coussy, F., El Botty, R., Chateau-Joubert, S., Servely, J.-L., de Plater, L., Assayag, F., Dahmani, A., Montaudon, E., Nemati, F., Fleury, J., Vacher, S., Gentien, D., Rapinat, A., Foidart, P., Sounni, N. E., Noël, A., Salomon, A., ... Reyal, F. (2018). Capecitabine efficacy is correlated with TYMP and RB expression in PDX established from triple-negative breast cancers. Clinical Cancer Research. doi:10.1158/1078-0432.CCR-17-3490
Peer Reviewed verified by ORBi

Yip, C., Foidart, P., Somja, J., Truong, A., Lienard, M., Feyereisen, E., SCHROEDER, H., GOFFLOT, S., Donneau, A.-F., COLLIGNON, J., Delvenne, P., Sounni, N. E., Jerusalem, G., & Noël, A. (2017). MT4-MMP and EGFR expression levels are key biomarkers for breast cancer patient response to chemotherapy and erlotinib. British Journal of Cancer. doi:10.1038/bjc.2017.23
Peer Reviewed verified by ORBi

Yip, C., FOIDART, P., SOMJA, J., Truong, A., COLLIGNON, J., DELVENNE, P., Sounni, N. E., JERUSALEM, G., & Noël, A. (03 December 2015). MT4-MMP, a potential prognostic factor in triple negative breast cancer [Paper presentation]. Séminaire des chercheurs Télévie 2016, Gembloux, Belgium.

Yip, C., FOIDART, P., SOMJA, J., Truong, A., COLLIGNON, J., DELVENNE, P., Sounni, N. E., JERUSALEM, G., & Noël, A. (September 2015). MT4-MMP, a potential therapeutic target in triple negative breast cancer [Poster presentation]. 2nd international society of cancer metabolism meeting - METABOLISM and MICROENVIRONMENT in CANCER PLASTICITY, Venise, Italy.

Contact ORBi